Table 2.
Laboratory tests of ICH patients.
| Hematological variables | Favorable outcome (n = 42) | Poor outcome (n = 59) | p value | ||
|---|---|---|---|---|---|
| Mean ± SD | Med (IQR 25–75 %) | Mean ± SD | Med (IQR 25–75 %) | ||
| Admission | |||||
| WBC (109/L) | 12.5 ± 3.3 | 11.8 (10.6–14.7) | 12.4 ± 6.2 | 11.3 (8.6–14.6) | 0.928 |
| Neutrophils (109/L) | 10.6 ± 3.0 | 10.4 (8.2–12.8) | 9.9 ± 4.8 | 9.3 (6.3–12.8) | 0.370 |
| Lymphocytes (109/L) | 1.3 ± 0.7 | 1.2 (0.8–1.6) | 1.7 ± 1.4 | 1.2 (0.9–1.7) | 0.165 |
| Platelets (109/L) | 226.0 ± 66.6 | 220.5 (171.3–270.3) | 216.0 ± 76.0 | 211.0 (163.0–246.0) | 0.496 |
| NLR1 | 9.9 ± 4.7 | 8.7 (6.5–12.6) | 8.7 ± 5.9 | 7.8 (4.0–11.6) | 0.276 |
| PLR1 | 202.9 ± 79.2 | 206.3 (143.6–271.8) | 174.3 ± 86.8 | 153.35 (105.7–222.2) | 0.094 |
| Glucose (mmol/L) | 8.3 ± 3.1 | 7.2 (6.2–10.0) | 9.3 ± 3.2 | 8.4 (6.7–11.4) | 0.117 |
| K+(mmol/L) | 3.7 ± 0.6 | 3.8 (3.4–4.0) | 3.7 ± 0.5 | 3.7 (3.4–4.1) | 0.994 |
| FIB(g/L) | 3.2 ± 0.8 | 3.1 (2.7–3.7) | 3.4 ± 1.4 | 3.1 (2.5–3.7) | 0.410 |
| PT(s) | 12.8 ± 1.4 | 12.7 (12.0–13.2) | 12.8 ± 0.9 | 12.7 (12.1–13.4) | 0.767 |
| APTT(s) | 31.8 ± 5.5 | 30.1 (28.3–34.2) | 31.6 ± 4.9 | 31.4 (27.5–34.5) | 0.853 |
| TT(s) | 17.0 ± 1.6 | 17.3 (15.9–18.0) | 17.0 ± 2.3 | 16.8 (15.9–18.0) | 0.989 |
| D-dimer(mg/l) | 1.3 ± 2.7 | 0.6 (0.4–1.1) | 1.2 ± 1.6 | 0.5 (0.3–1.1) | 0.674 |
| 48 h after surgery | |||||
| WBC (109/L) | 13.1 ± 3.4 | 10.7 (10.4–15.1) | 13.1 ± 3.2 | 13.2 (10.7–15.4) | 0.963 |
| Neutrophils (109/L) | 10.8 ± 2.9 | 10.8 (8.4–13.1) | 11.2 ± 3.2 | 10.7 (8.6–14.0) | 0.572 |
| Lymphocytes (109/L) | 1.3 ± 0.6 | 1.1 (0.9–1.6) | 1.1 ± 0.5 | 1.1 (0.7–1.5) | 0.044* |
| Platelets (109/L) | 212.9 ± 58.2 | 207.0 (175.3–258.0) | 206.2 ± 63.5 | 200.0 (163.0–246.0) | 0.589 |
| NLR2 | 9.3 ± 3.6 | 9.1 (6.6–11.8) | 13.7 ± 10.4 | 10.5 (6.2–17.0) | 0.004* |
| PLR2 | 183.9 ± 76.2 | 181.4 (111.7–245.4) | 234.8 ± 139.3 | 184.0 (127.5–307.5) | 0.021* |
| 3-7d after surgery | |||||
| WBC (109/L) | 10.1 ± 2.7 | 9.9 (8.8–11.6) | 11.2 ± 3.2 | 10.6 (9.1–13.7) | 0.085 |
| Neutrophils (109/L) | 7.7 ± 2.4 | 7.5 (5.8–9.4) | 8.7 ± 2.9 | 7.9 (6.8–11.3) | 0.072 |
| Lymphocytes (109/L) | 1.4 ± 0.7 | 1.4 (1.1–2.0) | 1.4 ± 0.7 | 1.3 (0.9–2.0) | 0.828 |
| Platelets (109/L) | 255.6 ± 82.2 | 267.5 (191.0–327.5) | 232.4 ± 89.0 | 213.0 (162.0–279.5) | 0.187 |
| NLR3 | 6.5 ± 3.3 | 5.1 (3.5–8.1) | 7.5 ± 4.8 | 6.6 (4.6–9.1) | 0.236 |
| PLR3 | 209.8 ± 107.4 | 165.8 (143.2–239.5) | 195.2 ± 103.4 | 163.6 (127.0–234.8) | 0.495 |
WBC, White blood cell; FIB, Fibrinogen; PT, Prothrombin time; APTT, Activated partial thromboplastin time; TT, Thrombin time; NLR1, admission neutrophil to lymphocyte ratio; PLR1, admission Platelet to lymphocyte ratio; NLR2, Neutrophil to lymphocyte ratio at 48 h after surgery; PLR2, Platelet to lymphocyte ratio at 48 h after surgery; NLR3, Neutrophil to lymphocyte ratio within 3–7 d after surgery; PLR3, Platelet to lymphocyte ratio within 3–7 d after surgery; Med, median; IQR, Interquartile range; SD, standard deviation; *p < 0.05.